Ac. Skanes et al., TORSADE-DE-POINTES WITH AMIODARONE IN A PATIENT WITH PREVIOUS TORSADEDURING BETA-RECEPTOR BLOCKADE, Canadian journal of cardiology, 13(4), 1997, pp. 383-386
Torsade de pointes is a potentially lethal ventricular arrhythmia that
is associated with prolonged QT intervals and is often caused by drug
s that prolong repolarization. Among the most common drugs that may ca
use torsade de pointes are antiarrhythmic drugs including quinidine, p
rocainamide, sotalol and newer class III antiarrhythmic agents. The in
cidence of torsade de pointes associated with amiodarone, however, is
reported to be much lower. A case is reported of amiodarone-induced to
rsade de pointes following the development of the same arrhythmia duri
ng betablocker use. This case illustrates that although the reported i
ncidence of torsade de pointes during amiodarone therapy is low, patie
nts with bradycardia-induced torsade de pointes may be a subgroup of p
atients who are at increased risk of this arrhythmia with amiodarone.